Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TR-012001 in Japanese patients with Parkinson's disease
jRCT2061230065Phase 2Completed
- Sponsor
- SNLD
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Parkinson's disease (PD) comparing TR-012001 with Placebo (2 arms). Primary endpoints: Safety of TR-012001 and Pharmacokinetics of TR-012001. Started Jan 2024; status: completed.
02
Drugs
levodopa (intranasal, TR-012001)
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2061230065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061230065.